Cargando…

CD26-positive/CD326-negative circulating cancer cells as prognostic markers for colorectal cancer recurrence

The present study evaluated the presence and clinical relevance of a cluster of differentiation (CD)26(+)/CD326(−) subset of circulating tumor cells (CTCs) in pre- and post-operative blood samples of colorectal cancer patients, who had undergone curative or palliative intervention, in order to find...

Descripción completa

Detalles Bibliográficos
Autores principales:	LIETO, EVA, GALIZIA, GENNARO, ORDITURA, MICHELE, ROMANO, CIRO, ZAMBOLI, ANNA, CASTELLANO, PAOLO, MABILIA, ANDREA, AURICCHIO, ANNAMARIA, DE VITA, FERDINANDO, GEMEI, MARICA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2015
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301532/ https://www.ncbi.nlm.nih.gov/pubmed/25624884 http://dx.doi.org/10.3892/ol.2014.2749

Ejemplares similares

Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience
por: Galizia, Gennaro, et al.
Publicado: (2017)

Hepatoid carcinoma colliding with a liposarcoma of the left colon serosa presenting as an abdominal mass
por: Orditura, Michele, et al.
Publicado: (2007)

Neutrophil to lymphocyte ratio (NLR) for prediction of distant metastasis-free survival (DMFS) in early breast cancer: a propensity score-matched analysis
por: Orditura, Michele, et al.
Publicado: (2016)

Naples Prognostic Score Predicts Tumor Regression Grade in Resectable Gastric Cancer Treated with Preoperative Chemotherapy
por: Lieto, Eva, et al.
Publicado: (2021)

Perioperative Treatment in Resectable Gastric Cancer: Current Perspectives and Future Directions
por: Petrillo, Angelica, et al.
Publicado: (2019)

EpCAM (CD326) finding its role in cancer
por: Baeuerle, P A, et al.
Publicado: (2007)

EpCAM (CD326) finding its role in cancer
por: Baeuerle, P A, et al.
Publicado: (2007)

Targeting EpCAM (CD326) for immunotherapy in hepatoblastoma
por: Armeanu-Ebinger, Sorin, et al.
Publicado: (2013)

What’s New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives
por: Tirino, Giuseppe, et al.
Publicado: (2018)

CD26 and Cancer
por: Cordero, Oscar J.
Publicado: (2022)

Characterization of CD326-positive human hepatic stem cells
por: Schmelzer, Eva, et al.
Publicado: (2021)

Giant retroperitoneal liposarcoma treated with radical conservative surgery: A case report and review of literature
por: Lieto, Eva, et al.
Publicado: (2022)

The percentage of CD133+ cells in human colorectal cancer cell lines is influenced by Mycoplasma hyorhinis infection
por: Mariotti, Elisabetta, et al.
Publicado: (2010)

Mallory-Weiss syndrome from giant gastric trichobezoar: A case report
por: Lieto, Eva, et al.
Publicado: (2023)

MicroRNA‐326 negatively regulates CD155 expression in lung adenocarcinoma
por: Nakanishi, Takayuki, et al.
Publicado: (2023)

Prediction of SARS-CoV-2-Related Lung Inflammation Spreading by V:ERITAS (Vanvitelli Early Recognition of Inflamed Thoracic Areas Spreading)
por: Romano, Ciro, et al.
Publicado: (2022)

EpCAM (CD326) is differentially expressed in craniopharyngioma subtypes and Rathke’s cleft cysts
por: Thimsen, Vivian, et al.
Publicado: (2016)

A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients
por: De Vita, F, et al.
Publicado: (2005)

Subcutaneous Quadrantectomy Is a Safe Procedure in Management of Early-Stage Breast Cancer
por: Lieto, Eva, et al.
Publicado: (2022)

CD26-Related Serum Biomarkers: sCD26 Protein, DPP4 Activity, and Anti-CD26 Isotype Levels in a Colorectal Cancer-Screening Context
por: De Chiara, Loretta, et al.
Publicado: (2020)

Prognostic Significance of CD26 in Patients with Colorectal Cancer
por: Lam, Colin Siu-Chi, et al.
Publicado: (2014)

The Role of Serum CD26 in the Diagnosis of Gastric Cancer
por: Lee, Ju Yup, et al.
Publicado: (2022)

Microsatellite Status Detection in Gastrointestinal Cancers: PCR/NGS Is Mandatory in Negative/Patchy MMR Immunohistochemistry
por: Zito Marino, Federica, et al.
Publicado: (2022)

CD26-negative and CD26-positive tissue-resident fibroblasts contribute to functionally distinct CAF subpopulations in breast cancer
por: Houthuijzen, Julia M., et al.
Publicado: (2023)

MiR-326: Promising Biomarker for Cancer
por: Pan, Yao-Jie, et al.
Publicado: (2019)

A Subpopulation of Circulating Endothelial Cells Express CD109 and is Enriched in the Blood of Cancer Patients
por: Mancuso, Patrizia, et al.
Publicado: (2014)

The Role of Post-Translational Modifications of Chemokines by CD26 in Cancer
por: De Zutter, Alexandra, et al.
Publicado: (2021)

EpCAM (CD326) Regulates Intestinal Epithelial Integrity and Stem Cells via Rho-Associated Kinase
por: Ouchi, Takeshi, et al.
Publicado: (2021)

The influence of CD26(+) and CD26(−) fibroblasts on the regeneration of human dermo-epidermal skin substitutes
por: Michalak-Micka, Katarzyna, et al.
Publicado: (2022)

Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma
por: Andolfo, Immacolata, et al.
Publicado: (2011)

Plasma-derived extracellular vesicle surface markers CD45, CD326 and CD56 correlate with the stage of osteoarthritis: a primary study of a novel and promising diagnostic tool of the disease
por: Matejova, Jana, et al.
Publicado: (2023)

The role of CD26 and CD40 expression in therapeutic response - experimental study in oral cancer lines
por: Batista, Joana PN, et al.
Publicado: (2010)

Distinctive CD26 Expression on CD4 T-Cell Subsets
por: Cordero, Oscar J., et al.
Publicado: (2021)

First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers
por: Angevin, Eric, et al.
Publicado: (2017)

CD39 and CD326 Are Bona Fide Markers of Murine and Human Plasma Cells and Identify a Bone Marrow Specific Plasma Cell Subpopulation in Lupus
por: Dang, Van Duc, et al.
Publicado: (2022)

Antitumor Activity of Sorafenib in Human Cancer Cell Lines with Acquired Resistance to EGFR and VEGFR Tyrosine Kinase Inhibitors
por: Morgillo, Floriana, et al.
Publicado: (2011)

Circulating CD4(+) Treg, CD8(+) Treg, and CD3(+) γδ T Cell Subpopulations in Ovarian Cancer
por: Li, Rong, et al.
Publicado: (2023)

The P326 Gigatracker
por: Scarpa, Marcella
Publicado: (2006)

CD9 Negatively Regulates CD26 Expression and Inhibits CD26-Mediated Enhancement of Invasive Potential of Malignant Mesothelioma Cells
por: Okamoto, Toshihiro, et al.
Publicado: (2014)

NAB-paclitaxel and gemcitabine in metastatic pancreatic ductal adenocarcinoma (PDAC): from clinical trials to clinical practice
por: De Vita, Ferdinando, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_rsndq3dvppdkfm3sk0dr3hd7sd